Neoadjuvant olaparib feasible in BRCA-mutated ovarian cancer

Press/Media

Period	May 22 2023

Media coverage

Title	Neoadjuvant olaparib feasible in BRCA-mutated ovarian cancer
Media name/outlet	MIMS
Country/Territory	Singapore
Date	05/22/23
URL	https://specialty.mims.com/topic/neoadjuvant-olaparib-feasible-in-brca-mutated-ovarian-cancer-
Persons	Gina M. Mantia-Smaldone